Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1271 of 5804
-
New stroke drug aleeto enters human trials – could it limit brain damage?
Disease control Recruiting nowThis study is a prospective, double-blind, 1:1:1 randomized controlled study aimed at evaluating the efficacy and safety of Aleeto treatment compared to placebo in improving the NIHSS score at 14 days in patients with moderate to severe acute ischemic stroke. It also aims to expl…
Phase: PHASE2 • Sponsor: Beijing Tiantan Hospital • Aim: Disease control
Last updated Jun 26, 2026 12:34 UTC
-
App-Based rehab aims to ease chest pain in heart patients without blockages
Symptom relief Recruiting nowThis is a multi-site phase II, 2:1 pragmatic randomized trial of 250 participants within the NYU Langone Health (NYULH) and Emory University Medical Center system to evaluate mobile health cardiac rehabilitation (mHealth-CR) in patients who meet clinical criteria for INOCA (ische…
Phase: NA • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New antibiotic eye drops aim to cure pink eye faster
Disease control Recruiting nowThe purpose of this clinical trial is to demonstrate the superiority of fusidic acid 1% over placebo in adults and children with confirmed bacterial conjunctivitis and to further establish the safety profile of fusidic acid 1% for topical ocular administration.
Phase: PHASE3 • Sponsor: Baxis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New hope for chronic hives sufferers: experimental drug EVO756 under study
Symptom relief CompletedThis study will evaluate the efficacy and safety of different doses of EVO756 in adults with moderate to severe chronic spontaneous urticaria (CSU).
Phase: PHASE2 • Sponsor: Evommune, Inc. • Aim: Symptom relief
Last updated Jul 03, 2026 00:00 UTC
-
New drug TB006 aims to ease movement problems in Parkinson's
Disease control OngoingThe primary objectives of this study are to assess the efficacy of TB006 in improving motor function and to assess the safety of TB006 in participants with Parkinson's Disease (PD).
Phase: PHASE2 • Sponsor: TrueBinding, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New hope for advanced cancer: experimental drug BHV-1530 enters first human tests
Disease control Recruiting nowThis is a Phase 1, first in human (FIH), Open-Label, Dose Escalation, Dose Expansion and Dose Optimization Study of BHV-1530 as Monotherapy and in Combination with Other Anti-Cancer Agents in Adult Participants with Advanced or Metastatic Solid Tumors
Phase: PHASE1 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
Smartwatch-Style sensor aims to rehabilitate Stroke-Weakened arms
Symptom relief Recruiting nowThe proposed study is a two-arm randomized clinical trial designed to assess the effects of the StrokeWear system on clinical outcomes over a period of 6-months in chronic stroke survivors. The Intervention group will use StrokeWear system in combination to a motor and behavioral…
Phase: PHASE2 • Sponsor: Spaulding Rehabilitation Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:00 UTC
-
New hope for Hard-to-Treat colorectal cancer: targeted combo trial launches
Disease control OngoingKRAS is a common genetic mutation in tumors, and CRC is one of the tumors with a high KRAS mutation rate. The anti-tumor activity of KRAS G12C inhibitors combined with anti-EGFR anti-bodies have been proven in patients with advanced colorectal cancer, and one of them was approved…
Phase: PHASE1 • Sponsor: Jian Li • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New drug cocktail aims to shrink melanoma before surgery
Disease control Recruiting nowThe primary objective of this study is to evaluate the pathological response rate of neoadjuvant therapy with paclitaxel polymersomes for injection combined with carboplatin and adebrelimab in patients with resectable mucosal melanoma.Subjects will receive the combination therapy…
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
New hope for migraine sufferers? Needle-Freezing technique targets pain hub
Symptom relief CompletedPurpose of the Study: This study aims to evaluate the clinical effectiveness and long-term outcomes of "Sphenopalatine Ganglion (SPG) Pulsed Radiofrequency (PRF)" treatment in patients with chronic headaches and facial pain. The SPG is a major neural junction for craniofacial pai…
Phase: NA • Sponsor: Ankara City Hospital Bilkent • Aim: Symptom relief
Last updated Jun 27, 2026 11:02 UTC
-
Experimental muscle cell injection trial opens for duchenne patients
Disease control Recruiting nowThis is a single-center, single-arm, interventional phase 1 trial to evaluate the safety and tolerability of local injection of induced pluripotent stem cell (iPSC)- derived CD54+ allogeneic muscle progenitor cells in individuals with Duchenne muscular dystrophy (DMD)
Phase: PHASE1 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Stem cell shot could fix Worn-Out knees
Disease control Recruiting nowIn recent years, the incidence rate and disability rate of osteoarthritis have continued to grow, and it has become a common chronic disease of elderly patients, second only to the "three highs", and poses a continuous threat to China's medical and health system and public health…
Phase: PHASE2 • Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New PET tracer aims to spot Parkinson's protein in the brain
Diagnosis Recruiting nowThe goal of this clinical trial is to test whether we can reliably and safely measure the accumulation of pathological protein α-synuclein \[involved in some diseases such as Parkinson's disease, Lewy body dementia and Multiple System Atrophy (MSA), collectively named α-synuclein…
Phase: EARLY_PHASE1 • Sponsor: AC Immune SA • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
Mothers as health detectives: simple arm tape could save malnourished kids from relapse
Disease control Recruiting nowA 1:1:1 individually randomized unmasked controlled trial is proposed in which caregivers will be trained to screen their children who have recovered from an episode of SAM (severe acute malnutrition) using MUAC (mid-upper arm circumference) tapes. One arm will include caregiver …
Phase: NA • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New hope for young women with bone loss from missed periods
Disease control Recruiting nowThe goal of this study is to determine whether romosozumab will improve bone density in girls and women with functional hypothalamic amenorrhea (cessation of the menstrual period due to intense exercise, stress, or an eating disorder) who have low bone density. Participants will …
Phase: PHASE3 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Could a High-Fat diet tame bipolar mood swings in teens?
Disease control Recruiting nowThe present study is an open trial of ketogenic diets for adolescents and young adults (ages 12-21 yrs) in the depressive or mixed phases of bipolar disorder (BD). The investigators aim to determine whether combining standard of care pharmacological treatment for bipolar spectrum…
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Second-Time ACL repair: new technique shows promise for knee stability
Disease control Recruiting nowSeveral techniques for revision of anterior cruciate ligament (ACL) reconstruction and different types of grafts have been used over the years. These include single-bundle techniques, double-bundle techniques, and single-bundle techniques with external tenodesis. We also distingu…
Sponsor: Stefano Zaffagnini • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
New hope for stomach paralysis? trial combines two procedures
Disease control OngoingThis study is looking at how safe and effective G-POEM, GES and a combination of both are for people with severe stomach problems (gastroparesis) that haven't gotten better with medicine.
Phase: NA • Sponsor: Baylor Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC
-
Weight-Loss drug tirzepatide could double as psoriasis treatment in new trial
Disease control Recruiting nowThe main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with moderate-to-severe plaque PsO and obesity or overweight with at least 1 weight-related comorbidity. The study will last up…
Phase: PHASE4 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 13:01 UTC
-
New drug aims to calm painful skin flares in hidradenitis suppurativa
Disease control Recruiting nowThe purpose of this study is to assess efficacy safety and tolerability of HB0043 in adult patients with moderate to severe HS.
Phase: PHASE1, PHASE2 • Sponsor: Shanghai Huaota Biopharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC